Clinical Trial Update: Apremilast Therapy for Acute Gouty Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating apremilast for acute gouty arthritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Acute Gout | Phase 2 | Status: WITHDRAWN